(SeaPRwire) –   By: Oliver Hawthorne

Bridge to Life Ltd., a global innovator in organ preservation tech, announced oral presentations at the 2026 American Transplant Congress. The conference will be held in Boston from June 20 – 24. Presentations will spotlight Hypothermic Oxygenated Perfusion (HOPE) with VitaSmart in human uterus and small intestine transplants. One will compare HOPE with normothermic oxygenated perfusion in small intestine transplants.

Abstracts cover topics like HOPE for uterus transplants, donor serum FMN in liver transplants, and more. There’s also a symposium on machine perfusion advances. Bridge to Life offers products like VitaSmart Hypothermic Oxygenated Perfusion System. It serves leading transplant centers globally. This event could shape the future of organ transplantation.

Author bio: Oliver Hawthorne, Principal Correspondent at an international technology review.